Matthew Autterson is dedicated to helping others and improving the lives of those who suffer from neuropathic pain. Matthew’s commitment to others began in 1979, when he graduated from Michigan State University with a bachelor’s degree in Finance. He began his immaculate career after completing the University of Denver Tax Program and joined First Trust Corporation. In 1982, he joined Integrated Resources, Inc. a well-known financial services firm, which became incorporated as Resources Trust Company (RTC). In 1986, with Matthew at the helm of RTC the company experienced rapid growth and profitability. Matthew Autterson was now President of what became SunAmerica.
Matthew Autterson brokered a deal with AIG in 1998. SunAmerica was acquired by the giant AIG Company for $18 billion. A little over three years later AIG’s RTC division was the largest FDIC-insured trust company in the nation. In 2001, Fiserv would purchase the RTC division run by Matthew and would then manage a combined $32 billion. This was a full circle for Mathew as his first position was for First Trust Corporation, which was a subsidiary of Fiserv.
Matthew’s interest in business and accumulating wealth was to help others less fortunate then he was. He became a member of the board of directors for the Falci Adaptive Biosystems, a non-profit organization that helps people with neuro-motor disabilities. The company actively researches new techniques and discoveries to improve the functionality of individuals suffering from neuromotor disabilities and make their lives better in every way possible. Go To This Page for more information.
Mr. Autterson has always provided donations to various charitable organizations and is an active member on several boards of directors including the Webb-Waring Foundation, Denver Zoo, and Denver Zooological Foundation. All of these organizations try to make people’s lives better. Matthew has developed the Colorado society and continues to help those in pain. In 2013, Scott Falci created Falci Adaptive Biosystems and chose Matthew Autterson to be on the board of directors knowing Matthew would do what is best for those in need and the company as a whole.
Ever since Matthew’s career took off he has wanted to help others and now as the President and CEO of CNS Biosciences another non-profit organization created by Scott Falci. CNS Biosciences is a company that develops clinical-stage drugs that help those who suffer from neuropathic pain. Matthew Autterson and CNS research new discoveries and early-stage ideas to find new ways to alleviate pain and hopefully find a permanent cure for many disabilities.